Navigation Links
Uterus Size May Predict Risk for Premature Twins After IVF
Date:7/10/2008

Evaluation may help select women who are at lower risk for complications, study suggests

THURSDAY, July 10 (HealthDay News) -- Measuring the height of the uterus of a women pregnant with twins after in vitro fertilization (IVF) can help determine her risk of having the babies born prematurely, a new report says.

Doing this using ultrasound can help doctors and women decide how many embryos should be transferred in one IVF attempt, according to the research, presented Wednesday at the European Society of Human Reproduction & Embryology annual meeting, in Barcelona, Spain.

"Twin pregnancies account for between a quarter and a third of pregnancies obtained during IVF, and 8 percent of them are complicated by the babies being born extremely premature, leading to medical complications and sometimes fetal mortality," presenter Raphael Hirt, a fellow in the Division of Reproductive Medicine at the Hospital Antoine Bclre in Paris, said in a news release from the European Society. "For this reason, single embryo transfer is promoted as the best way of avoiding twin pregnancies, but, in some cases, this can alter the overall likelihood of pregnancy. An evaluation of a woman's individual risk of perinatal adverse outcomes from a twin pregnancy may help to select those women who have a lower risk of having twins born severely prematurely and who could consider a double embryo transfer if that is what they want."

The researchers had previously observed that women who already had children were less likely to give birth prematurely. They theorized that this was because the uterine cavity had been distended by the previous pregnancies.

Using transvaginal ultrasound (a process called hysterosonometry, or HSM), they measured uterus height of 79 women and followed them after having successful IVF treatment.

Women with the smallest uteri (less that 63 millimeters high) had a much greater chance of having babies born severely premature with an increased number of fetal deaths -- seven fetal deaths in this group compared with one in the women with medium-size uteri (between 64 and 70 millimeters high) and none among those with uterus height greater than 70 millimeters. Six deaths in the small uteri group were linked to prematurity, while the one death in the mid-sized group was not.

After adjusting for any confounding factors such as age, parity, previous premature delivery, the researchers found a clear association with HSM.

"Our results show that HSM is a reliable and noninvasive method for predicting twin-related severe prematurity and neonatal mortality, and it can be used before conception to help with objective decision-making about the number of embryos to transfer," Hirt said. "For women with an HSM measurement of less than 62mm, a single-embryo transfer is indicated, but in those with a longer uterine cavity, a double-embryo transfer can be considered if it is acceptable to the patients."

The researchers plan to use their new criteria going forward and see whether it results in decreased fetal mortality. They also plan to study whether a short uterine cavity affects single pregnancies to find whether it can identify which women may need intensive neonatal care.

More information

The National Institute of Child Health and Human Development has more about fertility and infertility.



-- Kevin McKeever



SOURCE: European Society for Human Reproduction & Embryology, news release, July 8, 2008


'/>"/>
Copyright©2008 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Removal of uterus increases risk of urinary incontinence
2. Research highlights problems of predicting birthweights in obese mothers
3. Single-nucleotide polymorphisms do not substantially improve risk prediction for breast cancer
4. Ankle-Arm Blood Pressure Test Predicts Heart Disease Risk
5. Thickness, Location Predict Skin Cancers Spread
6. New Method Better Predictor of In Vitro Fertilization Success
7. TB Outbreaks May Be Predicted by First 2 Cases
8. Elevated biomarkers predict risk for prostate cancer recurrence
9. ADHD Gene Doesnt Predict Response to Drugs
10. Cosmetic surgery procedures to exceed 55 million in 2015, ASPS study predicts
11. Simple ultrasound exam may predict osteoporosis risk
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/21/2017)... ... April 21, 2017 , ... ... finds that youth violence is declining—and at noteworthy rates. Between 2002 and 2014, ... young people involved in violence in the United States. The study, Trends ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... County that offers services to communities throughout the greater Pittsburgh metropolitan region, is ... drive to provide adaptive bicycles for differently-abled children. , Variety the Children’s Charity ...
(Date:4/21/2017)... ... April 21, 2017 , ... ... Agency of Record (AOR) for Theravent, Inc. , the makers of a ... company, Foundation Consumer Healthcare, is now working to expand distribution in anticipation of ...
(Date:4/21/2017)... ... ... Alive for Wellness is a group of clinical professionals and ... Alive team uses advanced behavioral sciences treatment modalities to accomplish their goals. ... struggle is based on 10 modalities of treatment that include: , ...
(Date:4/21/2017)... , ... April 21, 2017 ... ... promoting quality-based imaging practices, is seeking candidates to serve on its Accreditation ... imaging. , “RadSite’s ultimate mission is improving image quality and reducing ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)...  CVS Pharmacy, the retail division of CVS ... design to enhance the retail customer experience with ... and expanded beauty selections paired with informational signage ... offerings. Together with its innovative digital programs, these ... experience at CVS Pharmacy.  "Pharmacy ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
(Date:4/20/2017)... 20, 2017 Eyevensys, a private ... non-viral gene expression technology that enables the safe, local, ... address a wide range of ophthalmic diseases, announces it ... products Regulatory Agency (MHRA) to advance its technology into ... ...
Breaking Medicine Technology: